Sova Health Launches Gut Microbiome & Food Intolerance Tests to Advance Personalised Digestive Care

The new diagnostics leverage India’s largest proprietary gut microbiome database, built using whole genome sequencing of more than 35,000 samples.

Sova Health, which positions itself as India’s first full-stack gut health company, has launched two new diagnostic tools, the Gut Microbiome Test (GMT) and the Food Intolerance Test (FIT)—aimed at providing science-backed, personalized digestive health solutions.

The launch is part of the company’s broader strategy to shift gut health management from symptom-based approaches to data-driven interventions.

Whole Genome Sequencing Powers Precision Diagnostics

The new diagnostics leverage India’s largest proprietary gut microbiome database, built using whole genome sequencing of more than 35,000 samples.

The Gut Microbiome Test analyses a user’s gut bacteria composition, short-chain fatty acid (SCFA) levels, and key metabolic markers. Meanwhile, the Food Intolerance Test aims to identify sensitivities that may be contributing to chronic digestive issues.

Together, these tools are designed to offer more precise and actionable insights compared to conventional approaches.

Max Kushnir, Co-founder and Chief Scientific Officer at Sova Health, said the company aims to combine genomic technology with practical healthcare solutions.

“By leveraging genomic sequencing, we are bringing accuracy and personalization to gut health solutions like never before,” he said. “These tests empower individuals to take charge of their digestive health through tailored, science-backed insights.”

Integrated Gut Health Solutions & Data Privacy

Sova Health integrates these diagnostic tools into a broader ecosystem that includes personalized dietary recommendations and custom probiotic formulations, such as its flagship product, SovaX, launched in October 2024.

SovaX is touted as Asia’s first custom-made probiotic supplement, formulated based on an individual’s gut profile.

Patient data protection remains a priority. The company follows the Indian Council of Medical Research (ICMR) guidelines and gives users the option to request the deletion of their data at any time.

Tanveer Singh, Co-founder of Sova Health, said the company is committed to expanding access to evidence-based digestive care.

“Our goal is to ensure that individuals no longer have to rely on generic remedies. With our latest diagnostics and products, we aim to deliver truly personalized care,” he said.

Following the early adoption of GMT and FIT, the company reports improved outcomes in users with chronic digestive issues, such as reduced symptoms and lower dependence on conventional treatments.

Looking ahead, Sova Health plans to expand its diagnostic offerings to include tests targeting the skin and oral microbiome, as well as whole-body metabolic marker analysis, in an effort to build a more comprehensive personalized health platform.

Stay tuned for more such updates on Digital Health News.